MGI's DNBSEQ-G50 sequencer now has a major upgrade, with improvements to flexibility, turnaround time and performance. The original flow cell was upgraded from 300M reads to 500M reads and a longer read length of PE150 has been released. The sequencing chemistry has been optimized to provide faster ...

COVID-19 has caused a major epidemic worldwide. However, much is yet to be known about the epidemiology and evolution of the virus. One reason is that the challenges underneath sequencing HCoV-19 directly from clinical samples have not been completely tackled. BGI researchers completed the first wor...

BGI Group has been at the forefront in the fight against COVID-19. Starting from building a lab in Wuhan, sequencing the first 2019-nCoV virus genome to supplying extraction kits and automation for over 1,000,000 tests in more than 60 countries. MGI focuses on building core tools and technology to ...

In this webinar, Professor Lachlan Coin from University of Melbourne will talk about his recent study for de novo assembly of the genome of Australia’s vulnerable plant species, Macadamia jansenii. In this study several long read sequencing technologies, including MGI’s unique single-tube Long Fra...

BGI Group has been at the forefront in the fight against COVID-19. Starting from building a lab in Wuhan, sequencing the first 2019-nCoV virus genome and offering RT-PCR and sequencing-based detection packages. This webinar will present details of the BGI workflows for qPCR and sequencing that have ...

The current diagnosis of COVID-19 mainly depends on epidemiological history, clinical manifestations, laboratory examination, and imaging appearance. The clinical confirmation of suspected cases requires laboratory molecular tests on respiratory specimens or blood specimens - real-time fluorescent P...